16 January 2025
Plus500 Ltd.
("Plus500", the "Company" or, together with its subsidiaries, the "Group")
Inclusion in the STOXX Europe 600 Index
Plus500, a global multi-asset fintech group operating proprietary technology-based trading platforms, is pleased to announce that it has joined the STOXX Europe 600 Index (SXXP) effective as of the start of trading on Friday 17 January, 2025.
Plus500's inclusion in this widely followed, European-wide index is another testament to the strategic, operational and financial progress that the Group has made in recent years, notably with its ongoing expansion into new markets, launch of new products and successful deepening of engagement with customers.
Since its IPO on the London Stock Exchange in 2013, Plus500 has distributed approximately $2.3bn in shareholder returns, positioning it as the best performing company on the FTSE All-Share Index on a total return basis to the end of December, 2024. It maintains an extremely robust financial position, including a debt-free balance sheet with cash and cash equivalents amounting to c.$900m as of 31 December, 2024.
David Zruia, CEO of Plus500, commented:
"Plus500's inclusion in the STOXX Europe 600 Index for the first time is a significant milestone for the Group and serves as an important recognition for the compounding value creation we have delivered in recent years. With the Group's robust fundamentals, disciplined approach to capital allocation and strong cash generation, we look forward to continuing to execute against our strategic roadmap objectives and to delivering attractive and sustainable returns for our shareholders."
For further details:
Plus500 Ltd. | |
Elad Even-Chen, Chief Financial Officer Owen Jones, Head of Investor Relations | +972 4 8189503 +44 (0) 7551 654208
|
DGA Group | |
James Melville-Ross James Styles Methuselah Tanyanyiwa | +44 (0)20 7664 5095
|
About Plus500
Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures.
The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 60 countries and in 30 languages.
Plus500's trading platforms are accessible from multiple operating systems (iOS, Android and Windows) and web browsers. Customer care is, and has always been, integral to Plus500. As such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure, and stop losses to help customers protect profits, while limiting capital losses.
Plus500 was admitted to trading on the London Stock Exchange (LON: PLUS) on 24 July 2013. It was admitted to the Equity Shares in Commercial Companies" ("ESCC") Category of the Official List and is a constituent of the FTSE 250 Index. Website: www.plus500.com.
Forward looking statements
This announcement contains statements that are or may be forward-looking statements. All statements other than statements of historical facts included in this announcement may be forward-looking statements, including statements that relate to the Group's future prospects, developments and strategies. The Company does not accept any responsibility for the accuracy or completeness of any information reported by the press or other media, nor the fairness or appropriateness of any forecasts, views or opinions express by the press or other media regarding the Group. The Company makes no representation as to the appropriateness, accuracy, completeness or reliability of any such information or publication.
Forward-looking statements are identified by their use of terms and phrases such as "believe", "targets", "expects", "aim", "anticipate", "project", "would", "could", "envisage", "estimate", "intend", "may", "plan", "will" or the negative of those, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from those expressed or implied by such forward looking statements include, but are not limited to, those described in the Risk Management Framework section of the Company's most recent Annual Report. These forward- looking statements are based on numerous assumptions regarding the present and future business strategies of the Group and the environment in which it is and will operate in the future. All subsequent oral or written forward-looking statements attributed to the Company or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. Each forward-looking statement speaks only as of the date of this announcement. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither the Company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.